![](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/08/BioArctic-shutterstock_2219183715.jpg)
UAE approves BioArctic and Eisai’s Leqembi for Alzheimer’s disease
The Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved the use of BioArctic and Eisai’s Leqembi (lecanemab) for Alzheimer’s disease treatment. This decision by the UAE’s health authority allows the initiation of Leqembi …